Skip to main content
Bioresources and Bioprocessing
Fig. 6 | Bioresources and Bioprocessing

Fig. 6

From: Bigdata analytics identifies metabolic inhibitors and promoters for productivity improvement and optimization of monoclonal antibody (mAb) production process

Fig. 6

Validation results: The validation experiment demonstrated that the “high extreme” and “low extreme” conditions were able to provide a relative increase or decrease (respectively) in titer. The control condition that was used includes the four additional amino acids that were previously identified. Thus, an overall increase in titer can be observed based upon a previously optimized feeding condition

Back to article page